The plan to have New York regulate and control the price of prescription drugs will withstand legal challenges, Gov. Andrew Cuomo’s top health officials told state lawmakers at a joint budget hearing on Thursday.

“We considered and worked on this project and proposal for a good long time because we are well aware that other states have had proposals challenged in the courts,” said Jason Helgerson, the governor’s top Medicaid adivsor. “We are confident the governor’s proposal will stand up to any legal scrutiny.”

The proposal is aimed at creating a price ceiling for drug costs, cracking down of “abusive business practices” of pharmacy benefit managers and impose a fee on high-cos drugs when sold in the state.

Democratic Assemblyman John McDonald, a pharmacist, is skeptical of the proposal and its $55 million cost.

“I think today’s hearing is giving some insight into their strategy, which is if they put up a very strong policy, the manufacturers will adhere to it,” McDonald said.

But at the same time, he was taken aback by the degree of certainty Helgerson and Health Commissioner Howard Zucker had over the plan holding up in court given the struggles other states have had enacting similar policies.

“They were very clearly that it would. I was surprise to hear that,” he said. “Obviously it has not done well in other states, but at the end of the day there’s a $55 million price tag tied to this in the budget.”